Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Journal of Medical Economics Volume 23, 2020 - Issue 1

Submit an article Journal homepage

Open access

2,841

Views

CrossRef citations to date

Altmetric

Oncology

Healthcare resource utilization and costs associated with patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive NSCLC in the United States

Carl SamuelsenBoehringer Ingelheim International GmbH, Ingelheim, Germany; Correspondence[email protected]

Jonathan LimBoehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA;

Amanda GolembeskyBoehringer Ingelheim International GmbH, Ingelheim, Germany;

Sulena ShresthaSTATinMED Research, Plano, TX, USA

Li WangSTATinMED Research, Plano, TX, USA

Ingolf GriebschBoehringer Ingelheim International GmbH, Ingelheim, Germany;

Pages 48-53 | Received 17 May 2019, Accepted 16 Jul 2019, Published online: 09 Aug 2019

Cite this article
https://doi.org/10.1080/13696998.2019.1645681
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references